141045-28-5 Usage
Molecular structure
1H-Benzimidazole, 2,2'-(1,3-phenylene)bis[1-[(3,5-dimethoxyphenyl)methyl]consists of a benzimidazole ring (a bicyclic aromatic heterocycle containing a benzene ring fused to an imidazole ring) and a 2,2'-(1,3-phenylene)bis backbone (a phenylene bis compound with substituents).
Substituents
The compound contains 3,5-dimethoxyphenylmethyl groups, which are aromatic organic compounds.
Usage
This chemical is used in various industrial and research applications, including pharmaceuticals, dyes, and organic synthesis.
Potential applications
Due to its unique structure and properties, 1H-Benzimidazole, 2,2'-(1,3-phenylene)bis[1-[(3,5-dimethoxyphenyl)methyl]may have potential applications in medicinal chemistry and drug development.
Complexity
The compound is a complex chemical structure, which may contribute to its diverse range of applications and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 141045-28-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,0,4 and 5 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 141045-28:
(8*1)+(7*4)+(6*1)+(5*0)+(4*4)+(3*5)+(2*2)+(1*8)=85
85 % 10 = 5
So 141045-28-5 is a valid CAS Registry Number.
141045-28-5Relevant articles and documents
Self-assembly of dinuclear helical and nonhelical complexes with copper(I)
Rüttimann, Stéphane,Piguet, Claude,Bernardinelli, Gérald,Bocquet, Bernard,Williams, Alan F.
, p. 4230 - 4237 (2007/10/02)
The ligand 1,3-bis(1-methylbenzimidazol-2-yl)benzene (mbzimbe, L3) reacts with copper(I) to give [Cu2(L3)2](ClO4)2. The crystal structure of this compound (Cu2C44H36N8Cl2O 8, a = 13.661 (1) ?, b = 19.829 (3) ?, c = 15.413 (2) ?, orthorhombic, Pbca, Z = 4) shows a dinuclear centrosymmetrical nonhelical structure in which each copper is linearly coordinated by a benzimidazole group of each ligand. The complex displays a weak intramolecular stacking interaction between the benzene groups. This complex can be considered as a stereoconformer of the double-helical complex [Cu2(L1)2](ClO4)2 (L1; 2,6-bis(1-methylbenzimidazol-2-yl)pyridine). Conductivity measurements and UV-visible spectra show that the dimeric structures are maintained in solution in polar aprotic solvents. 1H NMR measurements show that [Cu2(L1)2]2+ retains its helical structure in solution. Comparison of helical and nonhelical structures with those formed by Cu(I) with related ligands allows discussion of the factors favoring the formation of self-assembled dinuclear complexes.
